JAZZ Stock Analysis: Buy, Sell, or Hold?
JAZZ - Jazz Pharmaceuticals, Inc.
$252.86
-5.52 (-2.14%)
▼
5d:
-0.4%
30d:
+6.46%
90d:
+24.55%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 03, 2026
TODAY
Get Alerted When JAZZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: JAZZ shows positive signals but monitor for confirmation. Market pricing in 6.2% growth. Moderate conviction.
💡 BUY OPPORTUNITY: JAZZ shows positive signals but monitor for confirmation. Market pricing in 6.2% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$242.12
Based on 2.8% avg growth
INTRINSIC VALUE TODAY
$150.34
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: JAZZ is currently trading at $252.86, which is considered slightly high relative to its 30-day fair value range of $236.42 to $253.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.8) compared to its historical average (8.2). At these levels, the market is pricing in 6.2% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, JAZZ is in a strong uptrend. Immediate support is located at $242.11, while resistance sits at $261.30.
Market Sentiment: JAZZ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, JAZZ is in a strong uptrend. Immediate support is located at $242.11, while resistance sits at $261.30.
Market Sentiment: JAZZ has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$236.42 -
$253.73
Company Quality Score
60/100
(HOLD)
Options IV Signal
20th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
73.1%
All Signals
- BULLISH: Options cheap (IV 20th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($266.90)
- BEARISH: Market expects 6.2% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$236.42 -
$253.73
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$14.30
(5.7%)
Support & Resistance Levels
Support Level
$242.11
Resistance Level
$261.30
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.83
Wall Street Target
$266.90
(+5.6%)
Revenue Growth (YoY)
19.1%
Earnings Growth (YoY)
3.2%
Profit Margin
0.7%
Valuation Premium vs History
+6.2% premium
PE vs Historical
9.8 vs 8.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.2%
(market-implied from PE analysis)
1-Year Target
$268.54
(+6%)
2-Year Target
$285.19
(+13%)
3-Year Target
$302.87
(+20%)
3-Yr Target (if PE normalizes)
(PE: 10→8)
PE COMPRESSION
$252.64
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 1.6%)
$559.86
(+121%)
Base:
(SPY PE: 9.8, Growth: 1.6%)
$265.49
(+5%)
Bear:
(PE: 8.2, Growth: 1.6%)
$221.46
(-12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Forward PE: 10.93 | Forward EPS (Implied): $23.14
Bull Case
$305.33
(+21%)
Analyst growth 15.0%, PE expands to 11.5
Base Case
$252.86
(0%)
Market implied 0.0%, PE stable at 10.9
Bear Case
$193.44
(-24%)
Severe decline -15.0%, PE contracts to 9.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 2:48 PM ET
Data refreshes hourly during market hours. Next update: 3:48 PM
Data refreshes hourly during market hours. Next update: 3:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JAZZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Bruce C Cozadd
SELL
6000 shares
2026-04-01
Patricia Carr
SELL
1287 shares
2026-03-09
Norbert G Riedel
SELL
3415 shares
2026-02-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 56 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$108 | 60 BUY |
Advanced JAZZ Option Strategies
Professional options setups generated by AI based on today's JAZZ price and gamma walls.
